Orasure Technologies, Inc
A maker of rapid point-of-care tests, OraSure Technologies is best known for the OraQuick HIV test that runs on a simple oral swab, along with tests for COVID-19, hepatitis C, syphilis, and sickle cell, plus sample-collection kits like Oragene and Colli-Pee used in clinics and at home. The company took its current form in 2000 when Epitope and STC Technologies merged, and its name blends "oral" (for its non-invasive mouth-based testing) with "sure." A fun twist: its Oragene saliva kits helped kick off the era of mail-order DNA testing from a simple spit sample.
Granted 2.94M · Bought 161.6K
Granted 460.1K · Bought 218.3K
Granted 392.7K · Sold 24.1K
Granted 119.9K
Granted 163.4K · Bought 47.7K
Granted 163.8K · Sold 1.8K
Granted 281.5K · Bought 17.1K
Granted 165.2K · Bought 6.0K
Granted 89.7K · Bought 75.0K
Granted 176.9K · Bought 7.0K
Granted 130.8K
Granted 95.5K
Granted 159.8K
Granted 24.8K · Bought 12.0K
Granted 20.0K · Bought 50.0K
Granted 78.1K
Granted 90.6K
Granted 75.5K
Granted 79.8K
Granted 20.0K
Granted 49.4K
Granted 30.6K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Eglinton Manner CarriePresident & CEO, Director · 20 transactions | — | 2.19M | 2.94M | 161.6K | — |
| McGrath Kenneth JChief Financial Officer · 17 transactions | — | 589.6K | 460.1K | 218.3K | — |
| Weber Kathleen GallagherChief Product Officer · 29 transactions | +317.7% | 399.5Kas of Mar 2025 | 392.7K | — | 24.1K |
| Tang Stephen S PHDPresident and CEO · 6 transactions | -5% | 247.1Kas of Feb 2022 | 119.9K | — | — |
| Kenny John P.Director · 8 transactions | — | 209.7K | 163.4K | 47.7K | — |
| Anthony Michele MarieSVP Finance & CAO · 19 transactions | — | 185.8K | 163.8K | — | 1.8K |
| Gagliano Nancy JDirector · 17 transactions | — | 185.1K | 281.5K | 17.1K | — |
| Aspinall Mara G.Director · 11 transactions | +397.4% | 178.8Kas of May 2025 | 165.2K | 6.0K | — |
| Boyd Steven KyleDirector · 8 transactions | — | 163.2K | 89.7K | 75.0K | — |
| Marmora LelioDirector · 12 transactions | +726.3% | 148.5K | 176.9K | 7.0K | — |
| Shulkin DavidDirector · 9 transactions | +408.5% | 126.3Kas of May 2025 | 130.8K | — | — |
| Jerrett Jack ESVP General Counsel &, CCO · 3 transactions | -5.7% | 124.6Kas of Dec 2021 | — | — | — |
| Nibauer LisaPresident of Diagnostics · 4 transactions | +283.1% | 123.5Kas of May 2022 | 95.5K | — | — |
| McMahon Robert W.Director · 7 transactions | — | 123.1K | 159.8K | — | — |
| Celano MichaelDirector · 3 transactions | +42.5% | 111.8Kas of Aug 2022 | 24.8K | 12.0K | — |
| Lancaster Ronny BDirector · 2 transactions | +201.3% | 104.8Kas of Aug 2022 | 20.0K | 50.0K | — |
| Gleason ScottInterim CFO/SVP IR · 3 transactions | — | 96.5Kas of May 2022 | 78.1K | — | — |
| Gallagher AgnieszkaGeneral Counsel &, CCO · 3 transactions | — | 90.6Kas of Feb 2022 | 90.6K | — | — |
| Datin James ADirector · 24 transactions | +206.5% | 82.1Kas of May 2024 | 75.5K | — | — |
| Bertrand John D.Director · 2 transactions | — | 79.8K | 79.8K | — | — |
| Hobbs Eamonn PDirector · 2 transactions | +40.1% | 61.5Kas of May 2022 | 20.0K | — | — |
| Miller Michele MarieVP, Finance and Controller · 5 transactions | +306.6% | 58.2Kas of Feb 2022 | 49.4K | — | — |
| Whitaker Anne ClemDirector · 4 transactions | — | 23.8Kas of May 2023 | 30.6K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last 5 years: +568.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.